Related content

Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS

By Aggelakis Konstantinos   Zacharaki Fani   Dardiotis Efthimios   Xiromerisiou Georgia   Tsimourtou Vana   Ralli Styliani   Gkaraveli Maria   Bourpoulas Dimitris   Rodopoulou Paraskevi   Papadimitriou Alexandros   Hadjigeorgiou Georgios  

Neurological Sciences, Vol. 31, Iss. 3, 2010-06 ,pp. : 253-257

Springer Publishing Company

Access to resources Recommend Favorite

Fulminant multiple sclerosis (MS)

By Rohani Mohammad  

Neurological Sciences, Vol. 32, Iss. 5, 2011-10 ,pp. : 953-957

Springer Publishing Company

Access to resources Recommend Favorite

Interhemispheric inhibition in patients with multiple sclerosis

By Boroojerdi B.   Hungs M.   Mull M.   Topper R.   Noth J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 109, Iss. 3, 1998-06 ,pp. : 230-237

Elsevier

Access to resources Recommend Favorite

Language Functions in Patients with Multiple Sclerosis

By Friend Karen B.   Rabin Bernard M.   Groninger Lowell   Deluty Robert H.   Bever Christopher   Grattan Lynn  

The Clinical Neuropsychologist (Neuropsychology, Development and Cognition: Sec, Vol. 13, Iss. 1, 1999-02 ,pp. : 78-94

Routledge Ltd

Access to resources Recommend Favorite

The MoSt Project––More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy

By Capra Ruggero   Battaglia Mario   Gaudioso Antonio   Lopes Laura   Paolicelli Damiano   Paoloni Marco   Pozzilli Carlo   Santilli Valter   Solaro Claudio   Trojano Maria  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 526-532

Springer Publishing Company

Access to resources Recommend Favorite